Concept information
Terme préférentiel
pharmaceuticals and clinical trials
Concept générique
Concepts spécifiques
- adverse drug reactions
- adverse events
- adverse selection and impact
- assurance
- Belmont report
- biotechnology
- blinding (clinical trials)
- case report form
- clinical research
- clinical trials
- Contract Research Organization
- control groups
- critical paths
- data management
- declaration of helsinki laws
- demographics
- drug coverage
- effective dose
- efficacy
- exclusion criteria
- Food and Drug Administration
- formularies
- generic drugs
- good clinical practices
- human research subjects
- inclusion criteria
- investigational new drug application
- in vitro testing
- in vivo testing
- Kefauver-Harris Amendments
- longitudinal study
- medical genetics
- MedWatch program
- National Institutes of Health
- new drug application
- off label
- open-ended study
- open-label study
- orphan drugs
- phase III study
- phase II study
- phase I study
- phase IV study
- pivotal studies
- placebos
- preclinical testing
- premedication
- price control in the pharmaceutical industry
- principal investigators
- protocol (involving human subjects)
- quality assurance
- randomization
- recruitment
- standard operating procedures
- standard treatment
- study arms
- subinvestigator
- vital signs
- vulnerable research subject population
Appartient au groupe
URI
http://data.loterre.fr/ark:/67375/N9J-PV4VSVWG-J
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}